Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancer
对晚期非小细胞肺癌患者使用帕博利珠单抗的剂量进行系统评价
期刊:Annals of Oncology
影响因子:65.4
doi:10.1093/annonc/mdw174
Chatterjee, M; Turner, D C; Felip, E; Lena, H; Cappuzzo, F; Horn, L; Garon, E B; Hui, R; Arkenau, H-T; Gubens, M A; Hellmann, M D; Dong, D; Li, C; Mayawala, K; Freshwater, T; Ahamadi, M; Stone, J; Lubiniecki, G M; Zhang, J; Im, E; De Alwis, D P; Kondic, A G; Fløtten, Ø